$225.60
-5.10-2.21%
In chiusura: Sep 25, 5:00 PM EST
$225.60
N/A
Post-mercato: Sep 25, 4:30 PM EST
Ascendis Pharma AS
ASNDNASDAQ
Ascendis Pharma Earnings & Forecasts
Ascendis Pharma (ASND) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Ascendis Pharma Guidance
Ascendis Pharma (ASND) ha pubblicato l'ultima guidance il gennaio 9, 2026 per fiscal year 2025. La società ha previsto un fatturato pari a $838.19M - $838.19M per il periodo.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.78 | $0.21 | $-0.06 | $-0.41 |
| Actual | $1.05 | $0.32 | $-0.64 | $-1.17 |
| Surprise | +34.6% | +52.4% | -966.7% | -185.1% |
| Revenue | ||||
| Estimate | $353.8M | $318.1M | $289.7M | $248.6M |
| Actual | $394.4M | $288.8M | $288.1M | $249.8M |
| Surprise | +11.5% | -9.21% | -0.55% | +0.46% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.13 | $1.41 | $1.45 | $2.00 |
| Revenue | ||||
| Consensus | $420.1M | $466.6M | — | — |